Acebutolol Hydrochloride
Product Images NDC 54868-5520
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acebutolol Hydrochloride (NDC 54868-5520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Of 200 mg Package Label (5520)
F1931f84-figure-01 (F1931f84 Figure 01)
F1931f84-figure-02 (F1931f84 Figure 02)
This table presents the percentage of adverse reactions experienced by participants in a study that compares the impact of the drugs Acebutolol, Propranolol, Hydrochlorothiazide, and Placebo on different body systems. The size of the participant groups for each drug is also listed. Adverse reactions are listed by body system and include Chest Pain, Edema, Depression, Dizziness, Headache, Nausea, Arthralgia, Myalgia, Cough, Dyspnea, Rhinitis, and Abnormal Vision.*
F1931f84-figure-03 (F1931f84 Figure 03)
This text appears to be a table with different body systems (cardiovascular, gastrointestinal, musculoskeletal, central nervous system, respiratory, skin, special senses, and urinary) and corresponding ratings (represented by letters, numbers, and percentages). It is not clear what these ratings represent or how they were obtained, so it is not possible to provide a more detailed description.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.